전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,373 programs
AntibodyLimited DatastaleMerckPhase 1

pembrolizumab (Keytruda, BAY1905254, Bapotulimab, Bapotulimab (BAY1905254) + Pembrolizumab (KEYTRUDA®))

Advanced Solid Tumor; Head and Neck Squamous Cell Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#monoclonal-antibody#HeadandNeckSquamousCellCarcinoma+1
Trials 1Status Active
AntibodyLimited DatastaleNovartisPhase 3

Simulect (Basiliximab, Basiliximab (Simulect))

Organ Transplantation, Renal Transplantation · Organ Transplantation, Renal Transplanta

#OrganTransplantationRenalTranspl#Antibody#Phase3#monoclonal-antibody#OrganTransplantation+2
Trials 1Status Active
AntibodyLimited DatastaleEli Lilly and CompanyPhase 2

Bebtelovimab (Bebtelovimab)

COVID-19 · COVID-19

#COVID-19#Antibody#Phase2#monoclonal-antibody#Eli
Trials 1Status Active
ADCLimited DatastaleWest China Second University Ho…Phase 2

MRG003 (Becotatug Vedotin, Becotatug Vedotin (MRG003))

Gastric Cancer; Gastroesophageal Junction (GEJ) Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase2#antibody-drug-conjugate#GastroesophagealJunctionGEJAdeno+1
Trials 1Status Recruiting
ADCLimited DatastaleWest China HospitalPhase 2

Becotatug Vedotin Combined with Ivonescimab (Becotatug Vedotin Combined with Ivonescimab)

Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#ADC#Phase2#antibody-drug-conjugate#West
Trials 1Status Recruiting
ADCLimited DatastaleFeng LiuPhase 2

Becotatug Vedotin Combined with PD-1 Inhibitor (Becotatug Vedotin Combined with PD-1 Inhibitor)

Head and Neck Squamous Cell Carcinoma · PD-1

#PD-1#ADC#Phase2#antibody-drug-conjugate#HeadandNeckSquamousCellCarcinoma+1
Trials 1Status Recruiting
ADCLimited DatastaleWest China HospitalPhase 2

Becotatug Vedotin Combined with Penpulimab (Becotatug Vedotin Combined with Penpulimab)

Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#ADC#Phase2#antibody-drug-conjugate#West
Trials 1Status Recruiting
ADCLimited DatastaleShanghai Ninth People's Hospita…Phase 2

Becotatug Vedotin combined with Pucotenlimab (Becotatug Vedotin combined with Pucotenlimab)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#ADC#Phase2#antibody-drug-conjugate#Shanghai
Trials 1Status Recruiting
ADCLimited DatastaleShanghai Ninth People's Hospita…Phase 2

sacituzumab govitecan (Trodelvy, Becotatug Vedotin or Sacituzumab Tirumotecan)

Adenoid Cystic Carcinoma of the Head and Neck; SBRT · Adenoid Cystic Carcinoma of the Head and

#AdenoidCysticCarcinomaoftheHeada#ADC#Phase2#antibody-drug-conjugate#SBRT+1
Trials 1Status Recruiting
ADCLimited DatastaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin every 8 weeks or 12 weeks as determined by Part 1 recommended dosages)

AL Amyloidosis; Amyloidosis · AL Amyloidosis

#ALAmyloidosis#ADC#Phase2#antibody-drug-conjugate#Amyloidosis+1
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity of CagliariPreclinical

Belimumab in SLE patients / Rituximab in RA patients (Belimumab in SLE patients / Rituximab in RA patients)

Systemic Lupus Erythematosus; Rheumatoid Arthritis · Systemic Lupus Erythematosus

#SystemicLupusErythematosus#Antibody#Preclinical#monoclonal-antibody#RheumatoidArthritis+1
Trials 1Status Active
AntibodyLimited DatastaleFujian Medical UniversityApproved

Bemosuzumab (Bemosuzumab)

Thyroid Neoplasms · Thyroid Neoplasms

#ThyroidNeoplasms#Antibody#Approved#monoclonal-antibody#Fujian
Trials 1Status Recruiting
AntibodyLimited DatastaleInternational Extranodal Lympho…Phase 2

Bendamustine and Rituximab (Bendamustine and Rituximab)

Marginal Zone B-cell Lymphoma · Marginal Zone B-cell Lymphoma

#MarginalZoneB-cellLymphoma#Antibody#Phase2#monoclonal-antibody#International
Trials 1Status Active
AntibodyLimited DatastaleXinqiao Hospital of ChongqingPhase 2

Benmelstobart combined with Bevacizumab and chemotherapy (Benmelstobart combined with Bevacizumab and chemotherapy)

NSCLC Stage IV Without EGFR/ALK Mutation · EGFR

#EGFR#Antibody#Phase2#monoclonal-antibody#NSCLCStageIVWithoutEGFR+2
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

ranibizumab (Lucentis, Bevacizumab, Ranibizumab)

Retinopathy of Prematurity Both Eyes · Retinopathy of Prematurity Both Eyes

#RetinopathyofPrematurityBothEyes#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
CGTAAVLimited DatastaleNeurologix, Inc.Phase 2

Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus (Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus)

Parkinson's Disease · Parkinson's Disease

#ParkinsonsDisease#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
AntibodyLimited DatastaleSanofiPreclinical

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis With Nasal Polyps

#ChronicRhinosinusitisWithNasalPo#Antibody#Preclinical#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
AntibodyLimited DatastaleHanyang University Seoul Hospit…Approved

Biological: Etanercept and its biosimilars (Biological: Etanercept and its biosimilars)

Ankylosing Spondylitis; Axial Spondyloarthritis · Ankylosing Spondylitis

#AnkylosingSpondylitis#Antibody#Approved#monoclonal-antibody#AxialSpondyloarthritis+1
Trials 1Status Active
AntibodyLimited DatastaleProthena Biosciences Ltd.Phase 3

Birtamimab (Birtamimab)

Light Chain (AL) Amyloidosis · Light Chain (AL) Amyloidosis

#LightChainALAmyloidosis#Antibody#Phase3#monoclonal-antibody#Prothena
Trials 1Status Discontinued
ADCLimited DatastaleAmgenPhase 2

Blinatumomab and Inotuzumab Ozogamicin (Blinatumomab and Inotuzumab Ozogamicin)

Acute Lymphoblastic Leukemia; Immunotherapy · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#ADC#Phase2#antibody-drug-conjugate#Immunotherapy+1
Trials 1Status Recruiting

54 / 119 pages

← PreviousNext →